These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1360820)

  • 1. Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.
    Müller MR; Lennartz K; Boogen C; Nowrousian MR; Rajewsky MF; Seeber S
    Ann Hematol; 1992 Nov; 65(5):206-12. PubMed ID: 1360820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
    Damiani D; Michieli M; Michelutti A; Melli C; Cerno M; Baccarani M
    Anticancer Drugs; 1993 Apr; 4(2):173-80. PubMed ID: 8098233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
    Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
    Biscardi M; Teodori E; Caporale R; Budriesi R; Balestri F; Scappini B; Gavazzi S; Grossi A
    Leuk Res; 2006 Jan; 30(1):1-8. PubMed ID: 16061283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
    Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Leuk Res; 1995 Nov; 19(11):823-9. PubMed ID: 8551799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
    Hu XF; Slater A; Kantharidis P; Rischin D; Juneja S; Rossi R; Lee G; Parkin JD; Zalcberg JR
    Blood; 1999 Jun; 93(12):4086-95. PubMed ID: 10361105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia.
    Boiron JM; Belloc F; Montastruc M; Cony-Makhoul P; Dumain P; Marit G; Mahon FX; Puntous M; Lopez F; Lacombe F
    Leuk Res; 1994 May; 18(5):313-8. PubMed ID: 8182921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy.
    Broxterman HJ; Sonneveld P; van Putten WJ; Lankelma J; Eekman CA; Ossenkoppele GJ; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Leukemia; 2000 Jun; 14(6):1018-24. PubMed ID: 10865967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
    Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
    Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.
    Salmon SE; Dalton WS; Grogan TM; Plezia P; Lehnert M; Roe DJ; Miller TP
    Blood; 1991 Jul; 78(1):44-50. PubMed ID: 1676918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.
    Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia.
    Styczyński J; Wysocki M; Debski R; Kurylak A; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Acta Biochim Pol; 2002; 49(1):99-107. PubMed ID: 12136962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
    Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
    Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
    Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
    Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.